SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-054325
Filing Date
2022-10-21
Accepted
2022-10-21 19:01:16
Documents
1
Period of Report
2022-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3659
  Complete submission text file 0001209191-22-054325.txt   5018
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 28 OVERLOOK DRIVE BEDFORD MA 01730
Business Address
TOMSICEK MICHAEL JOHN (Reporting) CIK: 0001570392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 221324604